Cresco Labs Inc.
CRLBF · OTCMCIK 1832928fmd_0SR4NEA79S07PGM5R70QAY145AManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 7 periods
Latest annual · FY2025
Millions- Total revenues
- 656
- Gross profit
- 325
- Operating income
- (28)
- Net income
- (135)
- Free cash flow
- 38
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -8.0%
- Revenue, 5 yearsFY2020 to FY2025
- +6.6%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Cresco Labs Inc. (CRLBF) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $655.8 million | $724.3 million | -9.5% | 40-F 2026-03-06 · proof |
| Gross profit | $324.6 million | $364.5 million | -10.9% | 40-F 2026-03-06 · proof |
| Operating income | -$28 million | $107.3 million | -126.1% | 40-F 2026-03-06 · proof |
| Net income | -$135.4 million | -$74.4 million | 40-F 2026-03-06 · proof | |
| Cash from operating activities | $72.9 million | $132.5 million | -45% | 40-F 2026-03-06 · proof |
| Free cash flow | $37.8 million | $113 million | -66.6% | 40-F 2026-03-06 · proof |
| Total assets | $1.2 billion | $1.4 billion | -11.7% | 40-F 2026-03-06 · proof |
| Total liabilities | $944.8 million | $967.2 million | -2.3% | 40-F 2026-03-06 · proof |
| Cash and cash equivalents | $57.9 million | $137.6 million | -57.9% | 40-F 2026-03-06 · proof |
| Total debt | $431.2 million | $475.3 million | -9.3% | 40-F 2026-03-06 · proof |
- What was Cresco Labs Inc. (CRLBF)'s revenue in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported revenue of $655.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $724.3 million the year before (-9.5%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What was Cresco Labs Inc. (CRLBF)'s gross profit in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported gross profit of $324.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $364.5 million the year before (-10.9%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What was Cresco Labs Inc. (CRLBF)'s operating income in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported operating income of -$28 million for fiscal 2025 (the year ended Dec 31, 2025), against $107.3 million the year before (-126.1%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What was Cresco Labs Inc. (CRLBF)'s net income in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported net income of -$135.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$74.4 million the year before. Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What was Cresco Labs Inc. (CRLBF)'s cash from operating activities in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported cash from operating activities of $72.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $132.5 million the year before (-45%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What was Cresco Labs Inc. (CRLBF)'s free cash flow in fiscal 2025?
- Cresco Labs Inc. (CRLBF) reported free cash flow of $37.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $113 million the year before (-66.6%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What are Cresco Labs Inc. (CRLBF)'s total assets?
- As of Dec 31, 2025, Cresco Labs Inc. (CRLBF) reported total assets of $1.2 billion, against $1.4 billion a year earlier (-11.7%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What are Cresco Labs Inc. (CRLBF)'s total liabilities?
- As of Dec 31, 2025, Cresco Labs Inc. (CRLBF) reported total liabilities of $944.8 million, against $967.2 million a year earlier (-2.3%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What are Cresco Labs Inc. (CRLBF)'s cash and cash equivalents?
- As of Dec 31, 2025, Cresco Labs Inc. (CRLBF) reported cash and cash equivalents of $57.9 million, against $137.6 million a year earlier (-57.9%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
- What is Cresco Labs Inc. (CRLBF)'s total debt?
- As of Dec 31, 2025, Cresco Labs Inc. (CRLBF) reported total debt of $431.2 million, against $475.3 million a year earlier (-9.3%). Source: the 40-F filed with the SEC on Mar 6, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CRLBF&period_type=annual&limit=5"Information only, not investment advice.